Mirabamides A-D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion.

PubWeight™: 1.72‹?› | Rank: Top 3%

🔗 View Article (PMID 17963357)

Published in J Nat Prod on October 27, 2007

Authors

Alberto Plaza1, Elena Gustchina, Heather L Baker, Michelle Kelly, Carole A Bewley

Author Affiliations

1: Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0820, USA.

Articles citing this

Cyclodepsipeptides from marine sponges: natural agents for drug research. Mar Drugs (2010) 1.10

Halogenated fatty acid amides and cyclic depsipeptides from an eastern Caribbean collection of the cyanobacterium Lyngbya majuscula. J Nat Prod (2009) 1.10

Mirabamides E-H, HIV-inhibitory depsipeptides from the sponge Stelletta clavosa. J Nat Prod (2011) 1.06

Celebesides A-C and theopapuamides B-D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry. J Org Chem (2009) 1.05

Nonproteinogenic amino acid building blocks for nonribosomal peptide and hybrid polyketide scaffolds. Angew Chem Int Ed Engl (2013) 1.02

Mutremdamide A and koshikamides C-H, peptide inhibitors of HIV-1 entry from different Theonella species. J Org Chem (2010) 0.95

Natural products from the Lithistida: a review of the literature since 2000. Mar Drugs (2011) 0.92

Potential anti-HIV agents from marine resources: an overview. Mar Drugs (2010) 0.91

Marine Peptides: Bioactivities and Applications. Mar Drugs (2015) 0.90

Characterizing the anti-HIV activity of papuamide A. Mar Drugs (2008) 0.89

Motualevic acids A-F, antimicrobial acids from the sponge Siliquariaspongia sp. Org Lett (2009) 0.89

Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening. J Biomol Screen (2009) 0.88

Biosynthetic chlorination of the piperazate residue in kutzneride biosynthesis by KthP. Biochemistry (2011) 0.86

Role of Marine Natural Products in the Genesis of Antiviral Agents. Chem Rev (2015) 0.82

Papuamides E and F, Cytotoxic Depsipeptides from the Marine Sponge Melophlus sp. Tetrahedron (2011) 0.81

Marine peptides and their anti-infective activities. Mar Drugs (2015) 0.79

Antiviral activity of natural products extracted from marine organisms. Bioimpacts (2011) 0.77

"Head-to-side-chain" cyclodepsipeptides of marine origin. Mar Drugs (2013) 0.77

Discovery and synthesis of namalide reveals a new anabaenopeptin scaffold and peptidase inhibitor. J Med Chem (2012) 0.77

The Pharmacological Potential of Non-ribosomal Peptides from Marine Sponge and Tunicates. Front Pharmacol (2016) 0.76

Marine Sponges as a Drug Treasure. Biomol Ther (Seoul) (2016) 0.76

Antiviral activity of animal venom peptides and related compounds. J Venom Anim Toxins Incl Trop Dis (2017) 0.75

Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications. Mar Drugs (2017) 0.75

Hydroxyproline-containing collagen peptide derived from the skin of the Alaska pollack inhibits HIV-1 infection. Mol Med Rep (2016) 0.75

Stellettapeptins A and B, HIV-inhibitory cyclic depsipeptides from the marine sponge Stelletta sp. Tetrahedron Lett (2015) 0.75

Synthesis and Spectroscopic Correlation of the Diastereoisomers of 2,3-Dihydroxy-2,6,8-trimethyldeca-(4Z, 6E)-dienoic Acid: Implications for the Structures of Papuamides A-D and Mirabamides A-D. Tetrahedron Asymmetry (2008) 0.75

Articles by these authors

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature (2011) 7.20

Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science (2007) 4.35

Patterns and distribution of tobacco consumption in India: cross sectional multilevel evidence from the 1998-9 national family health survey. BMJ (2004) 4.22

Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proc Natl Acad Sci U S A (2012) 2.69

Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16. Nat Struct Mol Biol (2013) 2.42

Global diversity of sponges (Porifera). PLoS One (2012) 2.12

The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog (2010) 2.03

Characterization of a culturable alphaproteobacterial symbiont common to many marine sponges and evidence for vertical transmission via sponge larvae. Appl Environ Microbiol (2006) 1.76

A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature (2013) 1.65

ENU mutagenesis, a way forward to understand gene function. Annu Rev Genomics Hum Genet (2008) 1.59

The manzamine alkaloids. Alkaloids Chem Biol (2003) 1.46

New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea. J Nat Prod (2002) 1.45

Mitochondrial genomes of two demosponges provide insights into an early stage of animal evolution. Mol Biol Evol (2005) 1.45

Reconstructing ordinal relationships in the Demospongiae using mitochondrial genomic data. Mol Phylogenet Evol (2008) 1.43

Discovery of an archetypal protein transport system in bacterial outer membranes. Nat Struct Mol Biol (2012) 1.41

Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion. J Biol Chem (2003) 1.34

Largamides A-H, unusual cyclic peptides from the marine cyanobacterium Oscillatoria sp. J Org Chem (2006) 1.31

Manadomanzamines A and B: a novel alkaloid ring system with potent activity against mycobacteria and HIV-1. J Am Chem Soc (2003) 1.27

Microbial and chemical transformation studies of the bioactive marine sesquiterpenes (S)-(+)-curcuphenol and -curcudiol isolated from a deep reef collection of the Jamaican sponge Didiscus oxeata. J Nat Prod (2002) 1.22

Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41. J Virol (2008) 1.21

Cyclic heptapeptides from the Jamaican sponge Stylissa caribica. J Nat Prod (2006) 1.20

Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation. Biochemistry (2005) 1.20

Characterization and HIV-1 fusion inhibitory properties of monoclonal Fabs obtained from a human non-immune phage library selected against diverse epitopes of the ectodomain of HIV-1 gp41. J Mol Biol (2005) 1.15

Using conjoined rigid body/torsion angle simulated annealing to determine the relative orientation of covalently linked protein domains from dipolar couplings. J Magn Reson (2002) 1.15

Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41. PLoS Pathog (2010) 1.14

RegA, an AraC-like protein, is a global transcriptional regulator that controls virulence gene expression in Citrobacter rodentium. Infect Immun (2008) 1.11

Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics. Virology (2008) 1.11

Crystal structures of the HIV-1 inhibitory cyanobacterial protein MVL free and bound to Man3GlcNAc2: structural basis for specificity and high-affinity binding to the core pentasaccharide from n-linked oligomannoside. J Biol Chem (2005) 1.10

Inhibition and kinetics of mycobacterium tuberculosis and mycobacterium smegmatis mycothiol-S-conjugate amidase by natural product inhibitors. Bioorg Med Chem (2003) 1.08

Mirabamides E-H, HIV-inhibitory depsipeptides from the sponge Stelletta clavosa. J Nat Prod (2011) 1.06

Celebesides A-C and theopapuamides B-D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry. J Org Chem (2009) 1.05

A monoclonal Fab derived from a human nonimmune phage library reveals a new epitope on gp41 and neutralizes diverse human immunodeficiency virus type 1 strains. J Virol (2007) 1.05

Structural basis for norovirus inhibition and fucose mimicry by citrate. J Virol (2011) 1.05

Salmahyrtisol A, a novel cytotoxic sesterterpene from the Red Sea sponge Hyrtios erecta. J Nat Prod (2002) 1.04

Alkaloids from the sponge Monanchora unguifera. J Nat Prod (2005) 1.03

Crambescidin 826 and dehydrocrambine A: new polycyclic guanidine alkaloids from the marine sponge Monanchora sp. that inhibit HIV-1 fusion. J Nat Prod (2003) 1.02

Secondary metabolites from three Florida sponges with antidepressant activity. J Nat Prod (2008) 1.02

Chrysophaentins A-H, antibacterial bisdiarylbutene macrocycles that inhibit the bacterial cell division protein FtsZ. J Am Chem Soc (2010) 1.01

Phylogenetic relationships of the marine Haplosclerida (Phylum Porifera) employing ribosomal (28S rRNA) and mitochondrial (cox1, nad1) gene sequence data. PLoS One (2011) 1.00

Batzelline D and isobatzelline E from the indopacific sponge Zyzzya fuliginosa. J Nat Prod (2002) 1.00

Cutting edge: pulmonary Legionella pneumophila is controlled by plasmacytoid dendritic cells but not type I IFN. J Immunol (2010) 1.00

Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV. J Med Chem (2005) 0.99

Lehualides A-D, metabolites from a Hawaiian sponge of the genus Plakortis. J Nat Prod (2005) 0.99

A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium. Cell Microbiol (2007) 0.98

Natural products, small molecules, and genetics in tuberculosis drug development. J Med Chem (2008) 0.98

Cytotoxic pyrroloiminoquinones from four new species of South African latrunculid sponges. J Nat Prod (2004) 0.97

Bromotyrosine-derived natural and synthetic products as inhibitors of mycothiol-S-conjugate amidase. Bioorg Med Chem Lett (2002) 0.96

Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry. Bioorg Med Chem (2008) 0.96

Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41. Biochemistry (2004) 0.96

Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity. J Biol Chem (2011) 0.96

Engineering an obligate domain-swapped dimer of cyanovirin-N with enhanced anti-HIV activity. J Am Chem Soc (2002) 0.96

Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants. J Mol Biol (2002) 0.96

Phylogeny of Tetillidae (Porifera, Demospongiae, Spirophorida) based on three molecular markers. Mol Phylogenet Evol (2013) 0.96

Anti-infective discorhabdins from a deep-water alaskan sponge of the genus Latrunculia. J Nat Prod (2010) 0.95

Shortcut to mycothiol analogues. Org Lett (2002) 0.95

Mutremdamide A and koshikamides C-H, peptide inhibitors of HIV-1 entry from different Theonella species. J Org Chem (2010) 0.95

Monitoring bacterial diversity of the marine sponge Ircinia strobilina upon transfer into aquaculture. Appl Environ Microbiol (2008) 0.94

Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry. ACS Chem Biol (2011) 0.94

Synthesis of natural product-inspired inhibitors of Mycobacterium tuberculosis mycothiol-associated enzymes: the first inhibitors of GlcNAc-Ins deacetylase. J Med Chem (2007) 0.93

Research achievement award--D. John Faulkner. J Nat Prod (2004) 0.91

A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruption. Biochemistry (2013) 0.90

Cytotoxic macrolides from a new species of the deep-water marine sponge Leiodermatium. J Org Chem (2006) 0.90

Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1. J Biol Chem (2012) 0.89

Motualevic acids A-F, antimicrobial acids from the sponge Siliquariaspongia sp. Org Lett (2009) 0.89

More kapakahines from the marine sponge Cribrochalina olemda. Org Lett (2003) 0.89

Advancement into the Arctic region for bioactive sponge secondary metabolites. Mar Drugs (2011) 0.88

Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening. J Biomol Screen (2009) 0.88

Synergistic inhibition of HIV-1 envelope-mediated membrane fusion by inhibitors targeting the N and C-terminal heptad repeats of gp41. J Mol Biol (2006) 0.88

Xestosaprols from the Indonesian marine sponge Xestospongia sp. J Nat Prod (2010) 0.87

Mirabalin, [corrected] an antitumor macrolide lactam from the marine sponge Siliquariaspongia mirabilis. J Nat Prod (2008) 0.87

Synthetic macrolides that inhibit breast cancer cell migration in vitro. J Am Chem Soc (2007) 0.87

Paltolides A--C, anabaenopeptin-type peptides from the palau sponge Theonella swinhoei. J Nat Prod (2010) 0.86

4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine-1-carbothioamide (ML267), a potent inhibitor of bacterial phosphopantetheinyl transferase that attenuates secondary metabolism and thwarts bacterial growth. J Med Chem (2014) 0.86

Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutralization potency and breadth. Virology (2009) 0.86

HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth. Expert Opin Ther Targets (2015) 0.86

Cloning, expression and rapid purification of active recombinant mycothiol ligase as B1 immunoglobulin binding domain of streptococcal protein G, glutathione-S-transferase and maltose binding protein fusion proteins in Mycobacterium smegmatis. Protein Expr Purif (2006) 0.85

A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants. Retrovirology (2012) 0.85

A meta-analysis of response inhibition and Stroop interference control deficits in adults with traumatic brain injury (TBI). J Clin Exp Neuropsychol (2011) 0.84

Antiviral and anticancer optimization studies of the DNA-binding marine natural product aaptamine. Chem Biol Drug Des (2008) 0.84

Dictazoles: potential vinyl cyclobutane biosynthetic precursors to the dictazolines. J Org Chem (2010) 0.84

Chrysophaentins are competitive inhibitors of FtsZ and inhibit Z-ring formation in live bacteria. Bioorg Med Chem (2013) 0.83

Dictazolines A and B, bisspiroimidazolidinones from the marine sponge Smenospongia cerebriformis. J Nat Prod (2008) 0.83

Crystallographic and NMR studies of antiinfective tricyclic guanidine alkaloids from the sponge Monanchora unguifera. Bioorg Med Chem (2004) 0.82

Utility of (His)6 tag for purification and refolding of proplasmepsin-2 and mutants with altered activation properties. Protein Expr Purif (2002) 0.82

Total synthesis and proof of structure of mycothiol bimane. J Am Chem Soc (2002) 0.82

Structures and potential antitumor activity of sesterterpenes from the marine sponge Hyrtios communis. J Nat Prod (2013) 0.81

Geographic variability and anti-staphylococcal activity of the chrysophaentins and their synthetic fragments. Mar Drugs (2012) 0.81

Anti-inflammatory sesquiterpene-quinones from the New Zealand sponge Dysidea cf. cristagalli. J Nat Prod (2005) 0.81

Topsentinols, 24-isopropyl steroids from the marine sponge Topsentia sp. J Nat Prod (2010) 0.81

Tamosterone Sulfates: A C-14 Epimeric Pair of Polyhydroxylated Sterols from a New Oceanapiid Sponge Genus. J Org Chem (1999) 0.81